New daily pill shows promise for weight loss in chinese adults
NCT ID NCT05890976
First seen Jan 28, 2026 · Last updated May 21, 2026 · Updated 13 times
Summary
This study tested whether a daily tablet of semaglutide (50 mg) helps Chinese adults with overweight or obesity lose weight. About 200 participants took either the drug or a placebo for 44 weeks, along with receiving advice on diet and exercise. The main goals were to see how much weight they lost and how many achieved at least a 5% reduction in body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Friendship Hospital, Capital Medical University-Endocrinology
Beijing, Beijing Municipality, 100050, China
-
Changzhou No.2 People's Hospital
Changzhou, Jiangsu, 213003, China
-
Chongqing University Three Gorges Hospital
Chongqing, Chongqing Municipality, 404000, China
-
General Hospital of Tianjin Medical University-Endocrinology
Tianjin, Tianjin Municipality, 300052, China
-
Huaihe Hospital of Henan University-Endocrinology
Kaifeng, Henan, 475000, China
-
Huashan Hospital Fudan University-Endocrinology
Shanghai, Shanghai Municipality, 200040, China
-
Huizhou Central People's Hospital-Endocrinology
Huizhou, Guangdong, 516001, China
-
Jinan Central Hospital
Ji'nan, Shandong, 250013, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Peking University People's Hospital-Endocrinology
Beijing, Beijing Municipality, 100044, China
-
Shanghai Pudong New Area People's Hospital-Endocrinology
Shanghai, Shanghai Municipality, 201200, China
-
Taihe Hospital-Endocrinology
Shiyan, Hubei, 442008, China
-
The Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, 212001, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, 450062, China
-
The First People's Hospital of Changde City-Endocrinology
Changde, Hunan, 415003, China
-
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210011, China
Conditions
Explore the condition pages connected to this study.